Health
ATPCI: Trimetazidine Fizzles for Post-PCI Angina – Medscape
The antianginal was unable to provide added benefit when added to optimal medical therapy, but one expert questions: Was the right population studied?
Adding trimetazidine to optimal medical therapy does not improve outcomes following successful percutaneous coronary intervention (PCI) for stable angina or a nonST-elevated myocardial infarction (MI), results of the ATPCI trial show.
There was no benefit for the composite primary endpoint of cardiac death, hospitalization for cardiac events, or recurrent/persistent angina requiring an addition, switch, or increased dose of antianginal therapies, or requiring coronary angiography (hazard ratio…
-
Noosa News18 hours agoLauren Ingrid Flanigan found unresponsive at Brisbane Women’s Correctional Centre
-
Noosa News16 hours agoTeenager dies from critical injuries after e-scooter crash on highway in Townsville
-
Business21 hours ago$5,000 invested in BHP shares 5 years ago is now worth…
-
Noosa News17 hours agoQld mother who allegedly killed daughter found ‘unresponsive’ in jail